- Home
- JAKK vs TLSA Comparison
JAKK vs TLSA Comparison
Compare JAKK & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JAKK
- TLSA
- Stock Information
- Founded
- JAKK 1995
- TLSA 2013
- Country
- JAKK United States
- TLSA United Kingdom
- Employees
- JAKK N/A
- TLSA N/A
- Industry
- JAKK Recreational Games/Products/Toys
- TLSA Biotechnology: Pharmaceutical Preparations
- Sector
- JAKK Consumer Discretionary
- TLSA Health Care
- Exchange
- JAKK Nasdaq
- TLSA Nasdaq
- Market Cap
- JAKK 231.8M
- TLSA 187.0M
- IPO Year
- JAKK 1996
- TLSA 2000
- Fundamental
- Price
- JAKK $17.71
- TLSA $2.50
- Analyst Decision
- JAKK Strong Buy
- TLSA
- Analyst Count
- JAKK 4
- TLSA 0
- Target Price
- JAKK $41.75
- TLSA N/A
- AVG Volume (30 Days)
- JAKK 188.5K
- TLSA 331.0K
- Earning Date
- JAKK 07-24-2025
- TLSA 08-05-2025
- Dividend Yield
- JAKK 5.65%
- TLSA N/A
- EPS Growth
- JAKK 25.15
- TLSA N/A
- EPS
- JAKK 3.34
- TLSA N/A
- Revenue
- JAKK $684,694,000.00
- TLSA N/A
- Revenue This Year
- JAKK N/A
- TLSA N/A
- Revenue Next Year
- JAKK $3.90
- TLSA N/A
- P/E Ratio
- JAKK $5.29
- TLSA N/A
- Revenue Growth
- JAKK 1.31
- TLSA N/A
- 52 Week Low
- JAKK $17.27
- TLSA $0.63
- 52 Week High
- JAKK $35.79
- TLSA $2.59
- Technical
- Relative Strength Index (RSI)
- JAKK 33.67
- TLSA 85.83
- Support Level
- JAKK $17.56
- TLSA $1.62
- Resistance Level
- JAKK $18.10
- TLSA $1.89
- Average True Range (ATR)
- JAKK 0.81
- TLSA 0.15
- MACD
- JAKK -0.22
- TLSA 0.09
- Stochastic Oscillator
- JAKK 8.78
- TLSA 92.25
About JAKK JAKKS Pacific Inc.
Jakks Pacific Inc is a multi-product line, multi-brand toy company that designs, produces, markets, sells and distributes toys and related kid-targeted consumer products, inclusive of kids indoor and outdoor furniture, costumes and various product lines in the sporting goods and home furnishings space. Its products offering include Traditional toys and electronics such as Action figures, Toy vehicles, Dolls and accessories, Ride-on toys, Toys for pets, and others. The company's products have been divided into two segments: (i) Toys/Consumer Products and (ii) Costumes.
About TLSA Tiziana Life Sciences Ltd.
Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.